The Virtual International COVID-19 and Diabetes Summit was held on August 26-27, 2020. To view recordings of each session, click the red links in the agenda below.
Wednesday, August 26, 2020
8:00
Opening Remarks
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California
8:05
Keynote: COVID-19 and Diabetes - Meeting the Challenge
Robert Gabbay, MD, PhD
American Diabetes Association, Arlington, Virginia, USA
Session 1: Preparedness
Background
Moderator
Juan Espinoza, MD, FAACP
Children's Hospital Los Angeles, USC, Los Angeles, California, USA
8:15
Historic Pandemics and Impact on Society
Thomas Ewing, PhD
Virginia Tech University, Blacksburg, Virginia, USA
Christopher McKnight Nichols, PhD
Oregon State University, Corvallis, Oregon, USA
8:45
Pathophysiology / Risk Factors for COVID-19
George Rutherford III, MD, MA
UCSF, San Francisco, California, USA
Mercedes Carnethon, PhD
Northwestern University, Chicago, Illinois, USA
Simin Liu, MD, ScD, MPH, MS
Brown University, Providence, Rhode Island, USA
Darin Olson, MD, PhD
Emory University, Atlanta, Georgia, USA
9:45
Social Determinants of COVID-19
Kristin Bennett, PhD
Rensselaer Polytechnic Institute, Troy, New York, USA
Vickie Mays, PhD
UCLA, Los Angeles, California, USA
10:10
Break
Resilience
Moderator
Bithika Thompson, MD
Mayo Clinic Arizona, Scottsdale, Arizona, USA
10:30
Preparing for the Future
Amesh Adalja, MD
Johns Hopkins University, Baltimore, Maryland, USA
10:50
Medications and Vaccines
Evan Martin Bloch, MB, ChB, MS
Johns Hopkins University, Baltimore, Maryland, USA
Daniel Griffin, MD, PhD
Columbia University, New York, New York, USA
David Kaslow, MD
PATH, Seattle, Washington, USA
Nevan Krogan, PhD
UCSF, San Francisco, California, USA
11:30
Psychology of Patients and Caregivers
Korey Hood, PhD
Stanford University, Stanford, California, USA
William Polonsky, PhD, CDCES
Behavioral Diabetes Institute, San Diego, California, USA
12:00
Lunch
Session 2: Response
Outpatient Care
Moderator
David Ahn, MD
Hoag Hospital, Newport Beach, California, USA
13:05
Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention
Nicholas Argento, MD, FACE
Maryland Endocrine, Columbia, Maryland, USA
Frank Best, MD
Die Diabetes-Praxis, Essen, Germany
Anders Carlson, MD
Park Nicollet International Diabetes Center, Minneapolis, Minnesota, USA
Curtiss Cook, MD
Mayo Clinic Arizona, Scottsdale, Arizona, USA
Deborah Wake, MBChB, BSc, PhD, Clin Ed Dip
University of Dundee, NHS Tayside, Dundee, Scotland, UK
14:05
Technology and Telemedicine for DM Outpatients
Eirik Årsand, PhD
UiT Arctic University of Norway, Tromsø, Norway
Juan Espinoza, MD, FAACP
Children's Hospital Los Angeles, USC, Los Angeles, California, USA
Aaron Neinstein, MD
UCSF, San Francisco, California, USA
Kirsten Nørgaard, MD, DMSc
Steno Diabetes Center, Copenhagen, Denmark
14:55
Break
Inpatient Care
Moderator
Amisha Wallia, MD, MS
Northwestern University, Chicago, Illinois, USA
15:20
Technology for Inpatients
Elias Spanakis, MD
University of Maryland School of Medicine, Baltimore, Maryland, USA
Kathleen Dungan, MD, MPH
Ohio State University, Columbus, Ohio, USA
Joshua Miller, MD, MPH
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA
15:50
Management of Diabetes Inpatients with COVID-19
Shivani Agarwal, MD, MPH
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
Joseph Aloi, MD
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA
Francisco Pasquel, MD, MPH
Emory University, Atlanta, Georgia, USA
Robert Rushakoff, MD
UCSF, San Francisco, California, USA
16:30
Ethics
Jacob M Appel, MD, JD, MPH
Icahn School of Medicine at Mount Sinai, New York City, New York, USA
James Tabery, PhD
University of Utah, Salt Lake City, Utah, USA
17:00
Adjourn
Thursday, August 27, 2020
8:00
Opening Remarks
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
8:05
Keynote: Knowledge Gaps and Research Opportunities for Diabetes and COVID-19
William Cefalu, MD
NIH, National Institute of Diabetes and Digestive and Kidney Diseases,
Bethesda, Maryland, USA
Session 3: Recovery
Resources
Moderator
Elias Spanakis, MD
University of Maryland School of Medicine, Baltimore, Maryland, USA
8:15
Accuracy of Diagnostic Tests
Jonathan Schmitz, MD, PhD
Vanderbilt University, Nashville, Tennessee, USA
Nam Tran, PhD
UC Davis, Sacramento, California, USA
8:35
Children
Zoltan Antal, MD
Weill Cornell Medicine, New York, New York
Jennifer Raymond, MD, MCR
Children's Hospital Los Angeles, USC, Los Angeles, California, USA
8:55
Pregnancy
James Bernasko, MD
Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, USA
Lynn Yee, MD, MPH
Northwestern University, Chicago, Illinois, USA
9:15
Economics of Care for COVID-19
Lynn Barr, MPH
Caravan Health, Kansas City, Missouri, USA
Paul Gerrard, MD
McDermott+Consulting, Washington, DC
Wei-An (Andy) Lee, DO
Los Angeles County+USC Medical Center, Los Angeles, California, USA
Ateev Mehrotra, MD, MPH
Harvard University, Boston, Massachusetts, USA
10:15
Break
High Risk Groups
Moderator
Lauren Wisk, PhD
UCLA, Los Angeles, California, USA
10:30
Role of Industry
Daniel Chernavvsky, MD
Senior Director of Medical Affairs, Dexcom, San Diego, California, USA
Corinne Fantz, PhD, DABCC, FACB
Director of Medical and Scientific Affairs-POC, Roche Diagnostics, Indianapolis, Indiana
Rosalind Hollingsworth, PhD
Global Medical Franchise Head for Influenza/RSV, Sanofi Pasteur, Swiftwater, Pennsylvania, USA
Jordan Messler, MD, SFHM, FACP
Executive Director, Quality Initiatives, Glytec Systems, Waltham, Massachusetts, USA
Matthew Taylor, CFA
MedTech Supplies & Devices Analyst, UBS-ARC, New York, New York, USA
11:20
Protection of Healthcare Workers
Marissa Baker, PhD
University of Washington, Seattle, Washington, USA
Shuhan He, MD
Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA
David Weissman, MD
CDC National Institute for Occupational Safety and Health, Washington, DC
11:50
Patients
4 Patients
12:10
Lunch
Session 4: Surveillance
Regulation
Moderator
Kong Chen, PhD, MSCI
NIH, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland, USA
13:15
International Responses to COVID-19
Patricia Gomez, MD
Universidad de Chile, Santiago, Chile
David O’Neal, MD, FRACP
St. Vincent's Hospital, University of Melbourne, Victoria, Melbourne, Australia
Gerry Rayman, MD, FRCP
NHS England, Richmond House, London, England
Eun-Jung Rhee, MD, PhD
Kangbuk Samsung Hospital, Seoul, South Korea
Laurien Sibomana, MS
Rwandan Diabetes Association, Kigali, Rwanda, Africa
Kayo Waki, MD, MPH, PhD
University of Tokyo Graduate School of Medicine, Tokyo, Japan
13:45
Government Policy
Ronald Goodstein, PhD
Georgetown University, Washington, DC
Venkat Narayan, MD, MSc, MBA
Emory University, Atlanta, Georgia, USA
Nancy Nielsen, MD, PhD
University at Buffalo, Buffalo, New York, USA
Bruce Quinn, MD, PhD
Bruce Quinn Associates LLC, Los Angeles, California, USA
14:25
Regulation of Tests and Treatments
Alexander Fleming, MD
Kinexum Services LLC, Harpers Ferry, West Virginia, USA
Alberto Gutierrez, PhD
NDA Partners LLC, Rochelle, Virginia, USA
Yarmela Pavlovic, JD
Manatt Health, San Francisco, California, USA
14:55
Break
The Future
Moderator
Gerard Coté, PhD
Texas A&M University, College Station, Texas, USA
15:20
Digital Health Technology
Jeffrey Joseph, DO
Thomas Jefferson University, Philadelphia, Pennsylvania, USA
Jessie Juusola, PhD
Evidation Health, San Mateo, California, USA
Bill Evans, BA
Rock Health, San Francisco, California, USA
Kuldeep Singh Rajput, PhD
Biofourmis, Boston, Massachusetts, USA
16:00
Big Data Statistics
Christina Astley, MD, ScD
Boston Children’s Hospital, Harvard University, Boston, Massachusetts, USA
Bobak Mortazavi, PhD
Texas A&M University, College Station, Texas, USA
16:20
Patient Surveillance and Privacy
David A Drew, PhD
Massachusetts General Hospital, Harvard University, Boston, Massachusetts, USA
Elissa Weitzman, ScD, MSc
Boston Children's Hospital, Harvard University, Boston, Massachusetts, USA
T.S. Harvey, PhD
Vanderbilt University, Nashville, Tennessee, USA
Dave Kleidermacher, BS
Google, Mountain View, California, USA
16:50
What Have We Learned?
David Kerr, MBChB, DM, FRCP, FRCPE
Sansum Diabetes Research Institute, Santa Barbara, California, USA
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
17:00
Adjourn